<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00592566</url>
  </required_header>
  <id_info>
    <org_study_id>DDP2003</org_study_id>
    <secondary_id>RDG4630213</secondary_id>
    <nct_id>NCT00592566</nct_id>
  </id_info>
  <brief_title>Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis</brief_title>
  <official_title>An Open Randomized Controlled Trial of Desmopressin, and Dexamethasone as Adjunctive Therapy in Patients With Pulmonary Hemorrhage Associated With Leptospirosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thailand Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Pulmonary involvement in leptospirosis has been reported to be on the increase&#xD;
      and is emerging as the main cause of death due to leptospirosis in many countries, including&#xD;
      Thailand.&#xD;
&#xD;
      Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone&#xD;
      as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with&#xD;
      leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Numbe of eligible patients has been decreased over time.&#xD;
  </why_stopped>
  <start_date>July 2003</start_date>
  <completion_date type="Actual">October 2006</completion_date>
  <primary_completion_date type="Actual">October 2006</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>during in hospital admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days of mechanical ventilation</measure>
    <time_frame>during hospital admission</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Leptospirosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard supportive care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexamethasone treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Desmopressin treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone, desmopressin</intervention_name>
    <description>200 mg of dexamethasone IV infusion OD for 3 days or 0.3 microgram/ kg of desmopressin in 50 ml of saline, as a 30- minute infusion</description>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Minirin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients (&gt; 14 years) with suspected severe leptospirosis&#xD;
&#xD;
          -  patients who presented with acute fever (oral temperature more than 38.00 C for &lt;15&#xD;
             days) in the absence of an obvious focus of infection&#xD;
&#xD;
          -  In the opinion of the attending physician might have pulmonary hemorrhage (i.e.&#xD;
             history of hemoptysis, and/ or bilateral nodular or air space infiltration).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant or breastfeeding&#xD;
&#xD;
          -  those with history of bleeding disorder&#xD;
&#xD;
          -  those who had underlying diseases such as chronic liver disease, diabetes mellitus&#xD;
&#xD;
          -  those who received diuretic or glucocorticoid&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kanigar Niwattayakul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loei Hospital, Loei, Thailand:</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yupin Suputtamongkol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loei Hospital</name>
      <address>
        <city>Mueng</city>
        <state>Loei Province</state>
        <zip>45000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <study_first_submitted>January 1, 2008</study_first_submitted>
  <study_first_submitted_qc>January 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2008</study_first_posted>
  <last_update_submitted>January 11, 2008</last_update_submitted>
  <last_update_submitted_qc>January 11, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Yupin Suputtamongkol</name_title>
    <organization>Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand</organization>
  </responsible_party>
  <keyword>Severe leptospirosis</keyword>
  <keyword>Pulmonary hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leptospirosis</mesh_term>
    <mesh_term>Weil Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Deamino Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

